Download DNB 2020 June Immunohematology And Blood Transfusion Paper III Question Paper

Download Diplomate of National Board (DNB) 2020 June Immunohematology And Blood Transfusion Paper III Question Paper

FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
IMMUNOHEMATOLOGY AND BLOOD TRANSFUSION
PAPER-III
Time: 3 hours
IMHT/J/20/15/III
Max. Marks:100
Important Instructions:
Attempt al questions in order.
Each question carries 10 marks.
Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1.
Role of transfusion medicine specialist in ABO incompatible Kidney
10
Transplant.
2.
Pathophysiology, diagnosis and management of fetal and neo-natal
10
alloimmune thrombocytopenia.
3.
a) Functions of Hospital Transfusion Committee.
5+5
b) Rational use of blood components.
4.
a) Cryopreservation of peripheral blood stem cells.
5+5
b) Factors affecting the quality of cryopreserved stem cel s.
5.
a) Pathogenesis of Transfusion Associated Acute Lung Injury
5+5
(TRALI).
b) Strategies for prevention of TRALI.
6.
a) Massive Transfusion Protocols.
5+5
b) How wil you minimize the common side effects of massive
transfusion?
7.
a) Pathogenesis of trauma induced coagulopathy.
5+5
b) Blood component therapy in the management of trauma induced
coagulopathy.
8.
a) Methods of quantification of anti-D in an immunized mother.
5+5
b) Clinical significance of anti-D quantification in the management of
immunized mother.
P.T.O.
-1-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

---

FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
IMMUNOHEMATOLOGY AND BLOOD TRANSFUSION
PAPER-III
9.
a) Clinically significant red cell antibodies.
5+5
b) Cellular assays to decide hemolytic potential of red cell antibody.
10
a) Transfusion support in a case of dengue haemorrhagic syndrome.
5+5
b) Risk mitigation strategies for transfusion transmitted dengue in
India.
************
-2-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

---